Table 2 PSG and demographic measures.

From: A high-density electroencephalography study reveals abnormal sleep homeostasis in patients with rapid eye movement sleep behavior disorder

 

Non medicated controls

Medicated controls

RBD patients

F(2,24) value

ANOVA p value

Age

46.8 ± 12.5

47.4 ± 11

49.7 ± 11

0.155

0.858

Sex (F/M)

3/6

3/6

3/6

 

N/A

TST (min)

365.7 ± 70.8

396.6 ± 75.7

359.6 ± 74.7

0.649

0.532

WASO (min)

75.0 ± 47.1

89.8 ± 36.2

128.4 ± 58.5

2.957

0.071

SOL (min)

18.2 ± 35.6

37.9 ± 32.3

26.2 ± 25.2

0.902

0.419

REML (min)

91.4 ± 30.1

174.8 ± 91.7

183.1 ± 108.0

3.311

0.053

SE (%)

80.0 ± 15.0

75.9 ± 9.9

70.4 ± 13.0

1.215

0.314

N1 (%)

4.5 ± 2.3*^

12.8 ± 8.4^

8.2 ± 4.4 *

4.874

0.017

N2 (%)

58.2 ± 9.5

63.4 ± 12.9

64.0 ± 12.3

0.686

0.513

N3 (%)

14.9 ± 8.9^

4.8 ± 4.4^

8.6 ± 9.7

3.609

0.043

REM (%)

22.4 ± 3.8

19.1 ± 9.4

19.2 ± 8.1

0.588

0.563

Tonic REM (%)

84.0 ± 7.2

76.3 ± 11.8

73.1 ± 11.8

1.934

0.10

Phasic REM (%)

16.0 ± 7.2

23.7 ± 11.8

26.9 ± 11.8

1.934

0.10

ArI(#/h)

12.7 ± 4.6

15.5 ± 7.9

15.8 ± 4.2

0.778

0.471

AHI (#/h)

5.8 ± 5.85

8.2 ± 6.3

6.1 ± 6.7

0.364

0.699

PLMI (#/h)

1.3 ± 0.59

1.06 ± 1.0

0.6 ± 1.0

1.427

0.260

  1. Mean values (± standard deviation). Percentage values for sleep stages are expressed per total sleep time (TST).
  2. AHI apnea–hypopnea index, ArI Arousal index, PLMI Periodic leg movement index, SE Sleep efficiency (TST per time in bed), REML Rapid eye movement onset latency, SOL Sleep onset latency, WASO Wake after sleep onset.
  3. ^ and *indicate significant unpaired t-test at α < 0.05 between non-medicated and medicated controls, and between non-medicated controls and RBD patients respectively. Significant p values for the main ANOVA test are indicated in bold.
Back to article page